Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder

Journal of the International Neuropsychological Society

Volumn 18, Issue 3, 2012, Pages 556-564

  Bodner, Kimberly E ^a   Beversdorf, David Q ^a   Saklayen, Sanjida S ^b   Christ, Shawn E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adrenergic beta antagonists; Autistic disorder; Executive function; Norepinephrine; Prefrontal cortex; Working memory

Indexed keywords

EID: 84861050515     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617712000070     Document Type: Article

References (60)

1. Adleman, N., Menon, V., Blasey, C., White, C., Warsofsky, I., Glover, G., & Reiss, A. (2002). A developmental fMRI study of the Stroop color-word task. Neuroimage, 16, 61-75. doi:10.1006/nimg.2001.1046
2. Alexander, J.K., Hillier, A., Smith, R.M., Tivarus, M.E., & Beversdorf, D.Q. (2007). Beta-adrenergic modulation of cognitive flexibility during stress. Journal of Cognitive Neuroscience, 19, 468-478. doi:10.1162/jocn.2007.19.3.468
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (Fourth Edition-Revised). Washington, DC: APA.
4. Arnsten, A.F. (1998). Catecholamine modulation of prefrontal cortical cognitive function. Trends in Cognitive Sciences, 2, 436-447. doi:10.1016/S1364-6613(98)01240-6
5. Arnsten, A.F., & Li, B.M. (2005). Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biological Psychiatry, 57, 1377-1384. doi:10.1016/j.biopsych.2004.08.019
6. Aston-Jones, G., Rajkowski, J., & Cohen, J. (1999). Role of locus coeruleus in attention and behavioral flexibility. Biological Psychiatry, 46, 1309-1320. doi:10.1016/S0006-3223(99)00140-7
7. Barch, D.M., Carter, C.S., MacDonald, A.W., Braver, T.S., & Cohen, J.D. (2003). Context-processing deficits in schizophrenia: Diagnostic specificity, 4-week course, and relationships to clinical symptoms. Journal of Abnormal Psychology, 112, 132-143. doi:10.1037/0021-843X.112.1.132
8. Barthelemy, C., Bruneau, N., Cottet-Eymard, J.M., Domenech-Jouve, J., Garreau, B., Lelord, G., y Pyrin, L. (1988). Urinary free and conjugated catecholamines and metabolites in autistic children. Journal of Autism and Developmental Disorders, 18, 583-591. doi:10.1007/BF02211876
9. Berridge, C.W., & Waterhouse, B.D. (2003). The locus coeruleusnoradrenergic system: Modulation of behavioral state and statedependent cognitive processes. Brain Research Reviews, 42, 33-84. doi:10.1016 /S0165-0173(03)00143-7
10. Beversdorf, D.Q., Carpenter, A.L., Miller, R.F., Cios, J.S.,&Hillier, A. (2008). Effect of propranolol on verbal problem solving in autism spectrum disorder. Neurocase, 14, 378. doi:10.1080/13554790802368661
11. Buchsbaum, B., Greer, S., Chang, W., & Berman, K. (2005). Metaanalysis of neuroimaging studies of the Wisconsin Card-Sorting Task and component processes. Human Brain Mapping, 25, 35-45. doi:10.1002/hbm.20128
12. Campbell, H.L., Tivarus,M.E., Hillier, A., & Beversdorf, D.Q. (2008). Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacology Biochemistry and Behavior, 88, 222-229. doi:10.1016/j.pbb.2007.08.003
13. Christ, S.E., Holt, D.D., White, D.A., & Green, L. (2007). Inhibitory control in children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 37, 1155-1165. doi:10.1007/s10803-006-0259-y
14. Christ, S.E., Kester, L.E., Bodner, K.E., & Miles, J.H. (2011). Evidence for selective inhibitory impairment in individuals with autism spectrum disorder. Neuropsychology, 25, 690-701. doi:10.1037/a0024256
15. Chugani, D., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T.,yChugani, H.T. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666-669. doi:10.1111/j.1460-9568.1997.tb01635.x
16. Coull, J.T., Frith, C.D., Dolan, R.J., Frackowiak, R.S., & Grasby, P.M. (1997). The neural correlates of the noradrenergic modulation of human attention, arousal and learning. European Journal of Neuroscience, 9, 589-598. doi:10.1111/j.1460-9568.1997.tb01635.x
17. Coull, J.T., Middleton, H.C., Robbins, T.W., & Sahakian, B.J. (1995a). Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology, 120, 322-332. doi:10.1007/BF02311180
18. Coull, J.T., Middleton, H.C., Robbins, T.W., & Sahakian, B.J. (1995b). Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology, 120, 311-321. doi:10.1007/BF02311179
19. Damasio, A.R., & Maurer, R.G. (1978). A neurological model for childhood autism. Archives of Neurology, 35, 777-786. doi:10.1001/archneur.1978. 00500360001001
20. Dhossche, D., Applegate, H., Abraham, A., Maertens, P., Bland, L., Bencsath, A., & Martinez, J. (2002). Elevated plasma gammaaminobutyric acid (GABA) levels in autistic youngsters: Stimulus for a GABA hypothesis of autism. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 8(8), PR1-PR6. Retrieved from http://www.ncbi.nlm. nih.gov/pubmed/12165753
21. Fankhauser, M.P., Karumanchi, V.C., German, M.L., Yates, A., & Karumanchi, S.D. (1992). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. The Journal of Clinical Psychiatry, 53, 77-82. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1548248
22. Hasselmo, M.E., Linster, C., Patil, M., Ma, D., & Cekic, M. (1997). Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. Journal of Neurophysiology, 77, 3326-3339. Retrieved from http://jn.physiology.org/content/77/6/3326.short
23. Hill, E. (2004). Executive dysfunction in autism. Trends in Cognitive Science, 8, 26-32. doi:10.1016/j.tics.2003.11.003
24. Jäkälä, P., Riekkinen, M., Sirviö, J., Koivisto, E., Kejonen, K., Vanhanen, M., & Riekkinen, P. (1999). Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology, 20, 460-470. doi:10.1016/S0893-133X(98)00127-4
25. Jaselskis, C.A., Cook, Jr. E.H., Fletcher, K.E., & Leventhal, B.L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322-327. doi:10.1097/00004714-199210000-00005
26. Joseph, R.M., McGrath, L.M., & Tager-Flusberg, H. (2005). Executive dysfunction and its relation to language ability in verbal school-age children with autism. Developmental Neuropsychology, 27, 361-378. doi:10.1207/ s15326942dn2703-4
27. Just, M.A., Cherkassky, V., Keller, T., Kana, R.K., &Minshew, N.J. (2007). Functional and anatomical cortical underconnectivity in autism: Evidence from an fMRI study of an executive function task and corpus callosum morphometry. Cerebral Cortex, 17, 951-961. doi:10.1093/cercor/bhl006
28. Kelley, B.J., Yeager, K.R., Pepper, T.H., & Beversdorf, D.Q. (2005). Cognitive impairment in acute cocaine withdrawal. Cognitive & Behavioral Neurology, 18, 108-112. doi:10.1097/01.wnn.0000160823.61201.20
29. Kelley, B.J., Yeager, K.R., Pepper, T.H., Bornstein, R.A., & Beversdorf, D.Q. (2007). The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal. Neurocase, 13, 320-327. doi:10.1080/ 13554790701846148
30. Kenworthy, L., Yerys, B., Anthony, L., & Wallace, G. (2008). Understanding executive control in autism spectrum disorders in the lab and in the real world. Neuropsychology Review, 18, 320-338. doi:10.1007/s11065-008- 9077-7
31. Koshino, H., Carpenter, P.A., Minshew, N.J., Cherkassky, V.L., Keller, T.A., & Just, M.A. (2005). Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage, 24, 810-821. doi:10.1016/j. neuroimage.2004.09.028
32. Koshino, H., Kana, R.K., Keller, T.A., Cherkassky, V.L., Minshew, N.J., & Just, M.A. (2008). fMRI investigation of working memory for faces in autism: Visual coding and underconnectivity with frontal areas. Cerebral Cortex, 18, 289-300. doi:10.1093/cercor/bhm054
33. Lake, C.R., Ziegler, M.G., & Murphy, D.L. (1977). Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Archives of General Psychiatry, 34, 553-556. doi:10.1001/archpsyc.1977.01770170063005
34. Levitt, J., Blanton, R., Smalley, S., Thompson, P., Guthrie, D., McCracken, J., y Toga, A.W. (2003). Cortical sulcal maps in autism. Cerebral Cortex, 13, 728-735. doi:10.1093/cercor/13.7.728
35. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685. doi:10.1007/BF02172145
36. Martchek, M., Thevarkunnel, S., Bauman, M., Blatt, G., & Kemper, T. (2006). Lack of evidence of neuropathology in the locus coeruleus in autism. Acta Neuropathologica, 111, 497-499. doi:10.1007/s00401-006-0061-0
37. Milner, B., & Petrides, M. (1984). Behavioural effects of frontallobe lesions in man. Trends in Neurosciences, 7, 403-407. doi:10.1016/S0166-2236(84) 80143-5
38. Minderaa, R.B., Anderson, G.M., Volkmar, F.R., Akkerhuis, G.W., & Cohen, D.J. (1994). Noradrenergic and adrenergic functioning in autism. Biological Psychiatry, 36, 237-241. doi:10.1016/0006-3223(94)90605-x
39. Muhle, R., Trentacoste, S.V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 113, e472-e486. doi:10.1542/peds.113.5.e472
40. Myers, S.M., & Johnson, C.P. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162-1182. doi:10.1542/peds.2007- 2362
41. Narayanan, A., White, C.A., Saklayen, S., Scaduto, M.J., Carpenter, A.L., Abduljalil, A., y Beversdorf, D.Q. (2010). Effect of propranolol on functional connectivity in autism spectrum disorder: A pilot study. Brain Imaging and Behavior, 4, 189-197. doi:10.1007/s11682-010-9098-8
42. Nickl-Jockschat, T., Habel, U., Maria Michel, T., Manning, J., Laird, A.R., Fox, P.T.,yEickhoff, S.B. (2011). Brain structure anomalies in autism spectrum disorder: A meta-analysis of VBM studies using anatomic likelihood estimation. Human Brain Mapping, doi:10.1002/hbm.21299 [Epub ahead of print]
43. Ohnishi, T., Matsuda, H., Hashimoto, T., Kunihiro, T., Nishikawa, M., Uema, T., & Sasaki, M. (2000). Abnormal regional blood flow in childhood autism. Brain, 123, 1838-1844. doi:10.1093/brain/123.9.1838
44. Owen, A., McMillan, K., Laird, A., & Bullmore, E. (2005). N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies. Human Brain Mapping, 25, 46-59. doi:10.1002/hbm.20131
45. Ozonoff, S., Strayer, D., McMahon, W.M., & Fillouz, F. (1994). Executive function abilities in autism: An informational processing approach. Journal of Child Psychology & Psychiatry, 35, 1015-1031. doi:10.1111/j.1469-7610.1994.tb01807.x
46. Pennington, B.F., & Ozonoff, S. (1996). Executive functions and developmental psychopathology. Journal of Child Psychology & Psychiatry, 37, 51-87. doi:10.1111/j.1469-7610.1996.tb01380.x
47. Posey, D.J., Puntney, J.I., Sasher, T.M., Kem, D.L., & McDougle, C.J. (2004). Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: A retrospective analysis of 80 cases. Journal of Child and Adolescent Psychopharmacology, 14, 233-241. doi:10.1089/1044546041649084
48. Psychological Corporation (1999). Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychological Corporation.
49. Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E., & Pevsner, J. (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology, 57, 1618-1628. Retrieved from http://www.ncbi.nlm.nih. gov/pubmed/11706102
50. Rapin, I., & Katzman, R. (1998). Neurobiology of autism. Annals of Neurology, 43, 7-14. doi:10.1002/ana.410430106
51. Ratey, J.J., Bemporad, J., Sorgi, P., Bick, P., Polakoff, S., O'Driscoll, G., & Mikkelsen, E. (1987). Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults. Journal of Autism and Developmental Disorders, 17, 439-446. doi:10.1007/BF01487073
52. Riccio, C.A., Reynolds, C.R., Lowe, P., & Moore, J.J. (2002). The continuous performance test: A window on the neural substrates for attention? Archives of Clinical Neuropsychology, 17, 235-272. doi:10.1016/S0887-6177(01) 00111-1
53. Rosvold, H.E., Mirsky, A.F., Sarason, I., Bransome, E.D., & Beck, L.H. (1956). A continuous performance test of brain damage. Journal of Consulting Psychology, 20, 343-350. doi:10.1037/h0043220
54. Russell, J. (1997). Autism as an executive disorder. Oxford: Oxford University Press.
55. Salmond, C.H., de Haan, M., Friston, K.J., Gadian, D.G., & Vargha-Khadem, F. (2003). Investigating individual differences in brain abnormalities in autism. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 358(1430), 405-413. doi:10.1098/rstb. 2002.1210
56. Shallice, T. (1982). Specific impairments of planning. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 298, 199-209. doi:10.1098/rstb.1982.0082
57. Steele, S.D., Minshew, N.J., Luna, B., & Sweeney, J.A. (2007). Spatial working memory deficits in autism. Journal of Autism and Developmental Disorders, 37, 605-612. doi:10.1007/s10803-006-0202-2
58. Stuss, D.T., & Benson, D.F. (1986). The frontal lobes. New York: Raven.
59. Williams, D.L., Goldstein, G., & Minshew, N.J. (2006). The profile of memory function in children with autism. Neuropsychology, 20, 21-29. doi:10.1037/0894-4105.20.1.21
60. Williams, D.L., Goldstein, G., Carpenter, P.A., & Minshew, N.J. (2005). Verbal and spatial working memory in autism. Journal of Autism and Developmental Disorders, 35, 747-756. doi:10.1007/s10803-005-0021-x